Catalyst Wire Dossier Catalyst Wire Dossier

Prolia

denosumab · Amgen
Drug timelines are a Plus or Pro feature.

83 regulatory and trial events tracked for Prolia, covering 2010-06-01 to 2026-08-19. Get the full timeline:

Most recent: EMA Authorised: Prolia (denosumab) — Amgen Europe B.V.

See pricing